We reported the dual role of tumor-specific miRNAs as regulators of PD-1/PD-L1 as well as oncogenic drivers, emphasizing how these miRNAs could serve as both biomarkers and putative therapeutic targets. The gene discussed is PDCD1; the disease is neoplasm.